Breaking News

You are here » Indian-Commodity  :  Top News  :  Sun Pharma, SPARC get approval from USFDA for NDA of XELPROS

14-Sep2018

Sun Pharma, SPARC get approval from USFDA for NDA of XELPROS

Sun Pharmaceutical Industries and Sun Pharma Advanced Research Company (SPARC) have received approval from US Food and Drug Administration (USFDA) for the New Drug Application (NDA) of XELPROS (latanoprost ophthalmic emulsion) 0.005% for the reduction of elevated intraocular pressure (IOP, or pressure inside the eye) in patients with open-angle glaucoma or ocular hypertension. This approval is from Sun Pharma's Halol in Gujarat facility.

The company in-licensed XELPROS from SPARC in June 2015 and this approval will trigger a milestone payment to SPARC. SPARC is also eligible for milestone payments and royalties on commercialization of XELPROS in the US.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.


Related News

View all news

Copper futures end tad higher on Monday

Copper futures ended slightly higher on Monday, with hopes of a resolution to the US-China trade war outweighing the threat of higher US tariffs on Chinese goods. Copper prices improved further as the......

Gold futures extend winning streak to fourth straight session on Monday

Gold futures extended winning streak to fourth straight session by registering small gains on Monday, amid geopolitical uncertainty and an eased greenback. However, gains were limited due to thin volume......

Physical Rubber prices witness weakness on Monday

Physical Rubber prices showed weakness on Monday amidst dull volumes in the market. Spot prices for RSS-4 variety fell to Rs 120.50/ kg compared to its previous closing of Rs 121/ kg; while the RSS-5 variety......

Top News

View all news

Jumbo Finance gets shareholders' nod to increase borrowing limits up to Rs 30 crore

Jumbo Finance has received an approval to increase Borrowing Limits of the company up-to Rs 30 crore. The shareholders of the company at their meeting held on November 19, 2018, approved the same.Jumbo......

Alembic Pharma gets USFDA's nod for Vardenafil Hydrochloride Orally Disintegrating Tablets

Alembic Pharmaceuticals has received an approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Vardenafil Hydrochloride Orally Disintegrating Tablets,......

SRF expects total Rs 28 crore quantum of damage due to Cyclone GAJA

SRF is expecting a total Rs 28 crore quantum of damage caused, based on the initial assessment. The disruption of operations was due to Cyclone GAJA at the plant of Technical Textiles Business (Viralimalai)......